| Metric | Q4 2023 | Q3 2023 | Q4 2022 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $624M | — | $519M | — | 20.4% |
| Op. Income | $295M | — | $216M | — | 36.3% |
| Gross Margin | 74.1% | — | 72.9% | — | 1.2pp |
| Net Margin | 21.0% | — | 3.1% | — | 18.0pp |
| EPS (Diluted) | $0.36 | — | $0.05 | — | 620.0% |
| Free Cash Flow | -$133M | — | $38M | — | -451.4% |
| Item | Amount |
|---|---|
| REVENUE | $624M |
| Cost of Revenue | $162M |
| GROSS PROFIT | $462M |
| R&D Expenses | $0 |
| Selling & Marketing | $91M |
| General & Administrative | $62M |
| SG&A Expenses | $154M |
| Other Expenses | $14M |
| Operating Expenses | $168M |
| Cost & Expenses | $329M |
| OPERATING INCOME | $295M |
| Interest Income | $354M |
| Interest Expense | $188M |
| Other Income/Expenses | -$146M |
| INCOME BEFORE TAX | $149M |
| Income Tax Expense | $17M |
| NET INCOME | $131M |
| D&A | $32M |
| EBIT | $309M |
| EBITDA | $341M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $624M |
| Cost of Revenue | $162M |
| GROSS PROFIT | $462M |
| R&D Expenses | $0 |
| Selling & Marketing | $91M |
| General & Administrative | $62M |
| SG&A Expenses | $154M |
| Other Expenses | $14M |
| Operating Expenses | $168M |
| Cost & Expenses | $329M |
| OPERATING INCOME | $295M |
| Interest Income | $354M |
| Interest Expense | $188M |
| Other Income/Expenses | -$146M |
| INCOME BEFORE TAX | $149M |
| Income Tax Expense | $17M |
| NET INCOME | $131M |
| D&A | $32M |
| EBIT | $309M |
| EBITDA | $341M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $131M |
| Depreciation & Amortization | $45M |
| Stock-Based Compensation | $14M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $153M |
| Change in Working Capital | -$427M |
| OPERATING CASH FLOW | -$84M |
| Capital Expenditure | -$49M |
| Acquisitions (Net) | -$761.7K |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$294M |
| NET CASH FROM INVESTING | -$344M |
| Net Debt Issuance | $183M |
| Common Stock Repurchased | -$59M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$466.8K |
| NET CASH FROM FINANCING | $123M |
| FREE CASH FLOW | -$133M |
| Net Change in Cash | -$306M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $438M |
| Short-Term Investments | $2.0B |
| Net Receivables | $5.0B |
| Inventory | $0 |
| Other Current Assets | $78M |
| TOTAL CURRENT ASSETS | $7.5B |
| PP&E (Net) | $335M |
| Goodwill | $1.1B |
| Intangible Assets | $637M |
| Long-Term Investments | $26M |
| Tax Assets | $134M |
| Other Non-Current Assets | $59M |
| TOTAL NON-CURRENT ASSETS | $2.3B |
| TOTAL ASSETS | $9.8B |
| Account Payables | $104M |
| Short-Term Debt | $373M |
| Deferred Revenue | $1.2B |
| Other Current Liabilities | $129M |
| TOTAL CURRENT LIABILITIES | $5.8B |
| Long-Term Debt | $704M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $110M |
| Other Non-Current Liabilities | $202M |
| TOTAL NON-CURRENT LIABILITIES | $1.0B |
| TOTAL LIABILITIES | $6.9B |
| Common Stock | $15.3K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $235M |
| Treasury Stock | -$57M |
| Accum. Other Comp. Income | $2.8B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.9B |
| Minority Interest | $11M |
| TOTAL EQUITY | $3.0B |
| TOTAL LIABILITIES & EQUITY | $9.8B |
| Total Debt | $1.1B |
| Net Debt | $673M |
